The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 25, 2025

Filed:

Mar. 06, 2019
Applicants:

Institut National DE LA Sante ET DE LA Recherche Medicale (Inserm), Paris, FR;

Universite DE Lille, Lille, FR;

Centre Hospitalier Regional Universitaire DE Lille, Lille, FR;

Inventors:

Nacim Betrouni, Lille, FR;

Régis Bordet, Lille, FR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 5/00 (2006.01); A61B 5/055 (2006.01); G06T 7/00 (2017.01); G06T 7/10 (2017.01); G06T 7/40 (2017.01); G16H 30/40 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01);
U.S. Cl.
CPC ...
A61B 5/0042 (2013.01); A61B 5/055 (2013.01); A61B 5/4082 (2013.01); A61B 5/4088 (2013.01); A61B 5/7246 (2013.01); A61B 5/7267 (2013.01); A61B 5/7275 (2013.01); G06T 7/0012 (2013.01); G06T 7/10 (2017.01); G06T 7/40 (2013.01); G16H 30/40 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); A61B 2576/026 (2013.01); G06T 2207/10088 (2013.01); G06T 2207/30016 (2013.01);
Abstract

The present invention relates to a method for predicting neurodegenerative decline and/or its severity for a patient, especially of cognitive impairment (CI). Strokes and Parkinson's disease are frequently associated with occurrence of long-term cognitive impairment or dementia with still incompletely resolved mechanisms. The discovery of diagnostic and predictive biomarkers thus remains a major challenge. The method of the invention uses radiomics corresponding to texture features extracted from a plurality of previously-acquired medical brain images and correlated with previously-acquired clinical and/or biological data. A classifier is trained beforehand for learning these radiomics, and then operated on radiomics computed from at least one brain image of a patient to generate a score representative of its risks of neurodegenerative decline. By applying this method on a cohort ofMCI and non-MCI patients, the inventors show that MCI patients could be early predicted with a mean accuracy of 88%. In the same way, the method was able to discriminate very early stages of cognitive decline in a Parkinson's disease population of 100 patients.


Find Patent Forward Citations

Loading…